King Luther Capital Management Corp Has $4.82 Million Stock Position in HealthEquity, Inc. (NASDAQ:HQY)

King Luther Capital Management Corp boosted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 9.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 50,190 shares of the company's stock after purchasing an additional 4,343 shares during the period. King Luther Capital Management Corp owned 0.06% of HealthEquity worth $4,816,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the stock. Smartleaf Asset Management LLC raised its holdings in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after purchasing an additional 98 shares during the period. Louisiana State Employees Retirement System increased its position in HealthEquity by 0.4% during the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock worth $2,322,000 after buying an additional 100 shares during the last quarter. Oregon Public Employees Retirement Fund raised its stake in HealthEquity by 0.6% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock valued at $1,706,000 after buying an additional 100 shares during the period. State of Michigan Retirement System lifted its position in shares of HealthEquity by 0.5% in the fourth quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock valued at $1,988,000 after buying an additional 100 shares during the last quarter. Finally, Raymond James Trust N.A. boosted its stake in shares of HealthEquity by 4.8% during the 3rd quarter. Raymond James Trust N.A. now owns 2,905 shares of the company's stock worth $238,000 after acquiring an additional 132 shares during the period. 99.55% of the stock is currently owned by institutional investors.

Remove Ads

HealthEquity Price Performance

NASDAQ HQY traded down $1.81 during midday trading on Thursday, hitting $93.97. The company had a trading volume of 785,320 shares, compared to its average volume of 655,126. The company has a market capitalization of $8.14 billion, a PE ratio of 86.21, a P/E/G ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The firm has a 50-day moving average price of $105.74 and a 200-day moving average price of $94.94.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its quarterly earnings data on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter last year, the company earned $0.40 EPS. As a group, analysts anticipate that HealthEquity, Inc. will post 2.32 earnings per share for the current fiscal year.

Insider Activity at HealthEquity

In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total value of $639,917.50. Following the sale, the director now owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 2.20% of the stock is currently owned by insiders.

Analysts Set New Price Targets

HQY has been the topic of a number of research analyst reports. Mizuho initiated coverage on HealthEquity in a report on Wednesday, December 4th. They set an "outperform" rating and a $126.00 price target for the company. Raymond James raised their target price on shares of HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a research note on Tuesday, February 25th. BTIG Research upped their price target on shares of HealthEquity from $110.00 to $130.00 and gave the company a "buy" rating in a research note on Thursday, November 14th. Bank of America increased their price target on shares of HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a report on Wednesday, November 13th. Finally, Barrington Research boosted their price objective on HealthEquity from $105.00 to $120.00 and gave the stock an "outperform" rating in a report on Monday, December 2nd. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company's stock. According to MarketBeat.com, HealthEquity has a consensus rating of "Moderate Buy" and a consensus price target of $113.54.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.